Home Featured Page 144

Featured

Latest

Psychedelic Funding Update: Q3 2025

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Psyence Group Announces Amendment and Closing of Previously Announced Private Placement

atai Life Sciences to Participate in September Investor Events

Mindset Pharma Files National Patents Protecting Family 1 Application in 16...

BetterLife and Collaborators to Submit Key Joint Research Publication

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida...

MindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA...

PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™...

PsyBio Therapeutics to Present at Upcoming Investor Events in September 2022

PT353 – Dr. James Fadiman, Dr. Sam Gandy, & Dr. David...

Psychedelic Bulletin #117 – A Deep Dive Into Psilocybin for Alochol...

1...143144145...299 Page 144 of 299

Psychedelic Funding Update: Q3 2025

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Funding Update: Q3 2025

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Psyence Group Announces Amendment and Closing of Previously Announced Private Placement

atai Life Sciences to Participate in September Investor Events

Mindset Pharma Files National Patents Protecting Family 1 Application in 16...

BetterLife and Collaborators to Submit Key Joint Research Publication

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida...

MindMed to Participate in H.C. Wainwright Global Investment ConferenceUSA – EnglishUSA...

PharmaTher Announces Completion of IND-Enabling Pharmacokinetic and Tolerability Study with KETARX™...

PsyBio Therapeutics to Present at Upcoming Investor Events in September 2022

PT353 – Dr. James Fadiman, Dr. Sam Gandy, & Dr. David...

Psychedelic Bulletin #117 – A Deep Dive Into Psilocybin for Alochol...

EDITOR PICKS

Psychedelic Funding Update: Q3 2025

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY